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This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).SUMMARYPrenatal exposure to valproic acid (VPA), an established antiepileptic drug, has been reported to impair postnatal cognitive function in
children born toVPA-treated epilepticmothers. However, how these defects arise andhow they can be overcome remain unknown. Using
mice, we found that comparable postnatal cognitive functional impairment is very likely correlated to the untimely enhancement of
embryonic neurogenesis, which led to depletion of the neural precursor cell pool and consequently a decreased level of adult neurogen-
esis in the hippocampus. Moreover, hippocampal neurons in the offspring of VPA-treated mice showed abnormal morphology and
activity. Surprisingly, these impairments could be ameliorated by voluntary running. Our study suggests that although prenatal exposure
to antiepileptic drugs such as VPA may have detrimental effects that persist until adulthood, these effects may be offset by a simple
physical activity such as running.INTRODUCTION
Epilepsy is one of the most common neurological disor-
ders in the world and is characterized by uncontrollable
seizures (Chang and Lowenstein, 2003). Epilepsy can
affect anyone, at any age, and there are an estimated
50 million afflicted people worldwide (Meinardi et al.,
2001; Ngugi et al., 2010; Joint Epilepsy Council, 2011).
The incidence of epilepsy is estimated to be higher than
0.5 cases per 1,000 of population per year (Sander,
2003). Around 30% of sufferers are women of child-
bearing age (Joint Epilepsy Council, 2011). During
pregnancy, epileptic patients must balance the maternal
and fetal risks associated with seizures against the
potential teratogenicity of antiepileptic drugs (AEDs)
(Battino and Tomson, 2007). Although it was recently
reported that several commonly used AEDs could pro-
duce postnatal impairment of cognitive function if
taken during pregnancy (Meador et al., 2009, 2011,
2012, 2013), the precise pathology underlying such
impairment remains unknown, and effective treatments
for affected children of epileptic mothers who took
AEDs during their pregnancy are therefore currently
unavailable.996 Stem Cell Reports j Vol. 5 j 996–1009 j December 8, 2015 j ª2015 TheValproic acid (VPA [2-propylpentanoic acid]) is an estab-
lished drug in the long-term treatment of epilepsy (Blaheta
and Cinatl, 2002). Several studies have revealed that VPA
can directly inhibit histone deacetylase (HDAC) activity
and cause hyperacetylation of histones, thereby activating
gene transcription (Go¨ttlicher et al., 2001; Phiel et al.,
2001). VPA significantly impairs postnatal cognitive func-
tion (Meador et al., 2009, 2011, 2012, 2013) and can lead
to severe developmental defects if taken in early gestational
stages (DiLiberti et al., 1984; Nau et al., 1991).We have pre-
viously shown, in several culture systems, that VPA en-
hances neurogenesis and drives neural precursor cells
(NPCs) into the neuronal lineage over the glial lineage by
a process involving HDAC inhibition (Hsieh et al., 2004;
Abematsu et al., 2010; Juliandi et al., 2012). Here, we
show that comparable postnatal cognitive functional
impairment after prenatal VPA exposure in mice is caused
by the untimely enhancement of embryonic neurogenesis,
which leads to depletion of the NPCs pool and conse-
quently a decreased level of adult neurogenesis in the hip-
pocampus. We further show that hippocampal neurons in
the offspring of VPA-treated mice have an abnormal
morphology and activity. Nevertheless, these impairments
can be alleviated by voluntary running.Authors
Figure 1. Prenatal VPA Treatment Enhances Untimely Embryonic Neurogenesis
(A) Experimental timeline of prenatal VPA treatment. E, embryonic day.
(B) The region highlighted by the dashed black rectangle in E15.5 forebrain sections was used for analysis in (C) and (D). The image is
modified from the Electronic Prenatal Mouse Brain Atlas. Scale bar, 1 mm.
(C) The thickness of the region stained by immature neuron marker b-tubulin isotype III (TUJ1; magenta) is increased in the cortical hem
of VPA-treated mice. Scale bar, 100 mm.
(D) VPA treatment increases the production of TBR2+ intermediate neuronal progenitors (red) born in the dentate neuroepithelium. Scale
bar, 100 mm.
(E) Quantification of the density of TBR2+ in (D).
(F–I) The proportion of E14.5 BrdU-labeled NPCs (red) expressing NPC marker SOX2 (green; F and H) is reduced, while the ones that
had differentiated into NEUN+ neurons are increased at P7 hippocampus after embryonic VPA treatment (green; G and I). Scale
bars, 100 mm.
(legend continued on next page)
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RESULTS
VPA Enhances Embryonic Neurogenesis and Alters
Global Gene Expression through HDAC Inhibition
We orally administered VPA or vehicle (methylcellulose
[MC]) to pregnant mice on embryonic day (E)12.5 to
E14.5, a mid-gestational period when neurogenesis is
prominent (Figure 1A).We found that VPA increased global
histone acetylation (Figures S1B–S1D) and enhanced neu-
rogenesis as shown by the increased thickness of TUJ1
stained region in the cortical hem of VPA-treated mice
(Figure 1C) and increased production of TBR2-positive in-
termediate neuronal progenitors born in the dentate neu-
roepithelium (Figures 1D and 1E) in the developing mouse
brain (Figures 1B and S1A; see Figures S1E–S1G for embry-
onic cortex). We also found that VPA depleted the NPC
pool (Figures 1F and 1H, hippocampus; Figures S1E and
S1F, cortex) and reduced the number of proliferating
NPCs (Figures 1J and 1K, hippocampus; Figures S1H and
S1I, cortex). These results were compatible with our previ-
ous in vitro observations (Hsieh et al., 2004; Abematsu
et al., 2010; Juliandi et al., 2012). Moreover, we found
that the fraction of cells that had exited the cell cycle
(i.e., differentiated) was higher in the E15.5 forebrain of
VPA-treated mice, as shown by an increased number of
BrdU-retaining cells that were negative for the proliferation
marker KI-67 compared to BrdU-retaining cells that were
still KI-67-positive, after a single injection of BrdU on
E14.5 to label proliferating cells (Figures S1J and S1K).
These results show that VPA treatment enhances embry-
onic neurogenesis and reduces the pool of NPCs.
Phenotypic changes should be generally induced by gene
expression changes, and we wanted to examine whether
VPA-induced gene expression change is due to its HDAC in-
hibiting property. To this end, we administered VPA or val-
promide (VPM), an analog AED without HDAC-inhibiting
activity, and performed transcriptome analyses at three
time points after the final administration. We found that
3 hr after the last administration, global gene expression
in the E14.5 telencephalon was changed substantially by
VPA, but not by VPM (Figure S1L; GEO: GSE 42904). This
global change had almost completely disappeared in both
cortex and hippocampus at E18.5 and in hippocampus at
P84, although several genes still displayed differential
expression levels (Figure S1L). We have found previously
that VPM treatment increased neither global histone acet-
ylation nor neurogenesis (Abematsu et al., 2010). Although
VPA and VPM might have another pharmacological activ-(J and K) Embryonic VPA treatment reduces the number of highly proli
the P7 DG. See also Figure S1 for other immunostaining data in the c
MC, prenatal methylcellulose (vehicle); VPA, prenatal valproic acid. Da
the SD. *p < 0.05, **p < 0.01, ***p < 0.001, two-tailed t test. Scale
998 Stem Cell Reports j Vol. 5 j 996–1009 j December 8, 2015 j ª2015 Theity differences beside HDAC-inhibiting activity, taken
together our results strongly suggest that VPA alters global
gene expression mainly through its HDAC-inhibiting
property, and this alteration is short-lived, being restricted
mainly to the period when VPA was being given to
the mice.
Prenatal VPA Treatment Has the Long-Term Effect of
Impairing Adult Neurogenesis, Learning, andMemory
We next investigated whether the enhancement of neuro-
genesis and changes in gene expression caused by prenatal
VPA exposure during the period of prominent neurogene-
sis could lead to postnatal impairment of cognitive func-
tion, as reported in humans (Meador et al., 2009, 2011,
2012, 2013). We conducted several behavioral tests on
12- to 13-week-old male mice (Figure 2A). Although the
locomotor activity of VPA-treated mice declined, the
decline rate was very slight (Tables S1 and S2) so that we
could measure the emotional or cognitive behaviors. We
found indeed that VPA-treated mice performed poorly
mainly in tests that assessed learning and memory, such
as Y-maze (Figure 2B) and contextual and cued fear associa-
tive tests (Figures 2C–2E, S4A, S4C, and S4E; Table S1), but
not in the other tests (Table S1). VPA-treated mice have a
lower correct-arm alternation in Y-maze. VPA-treated
mice also have a lower freezing response in contextual
and cued fear associative tests than MC-treated mice (con-
trol), despite the fact that both groups have similar fear
response to foot shock during conditioning (Table S1), indi-
cating that hippocampal-dependent learning and memory
(Sarnyai et al., 2000; Van der Borght et al., 2007) are
impaired in the VPA-treated mice.
In light of these results, we decided to focus on adult
NPCs in the hippocampal dentate gyrus (DG), as they
have been shown to play a functional role in learning
and memory processes by undergoing neurogenesis to
generate adult-born neural cells (Zhao et al., 2008). We in-
jected BrdU once a day for 7 days into 12-week-old mice to
label proliferating NPCs in the DG and then sacrificed the
mice 1 day (to assess cell proliferation) or 4 weeks (to assess
cell survival and fate) after the last BrdU injection (Fig-
ure 3A). We found that the number of BrdU-retaining cells
in VPA-treated mice was lower at both time points than
that in MC-treated control mice (Figures 3B and 3C). We
also found fewer proliferating KI-67-positive cells in VPA-
treated mice (Figures S2A and S2B). When we traced the
fate of BrdU-retaining cells 4 weeks after the last BrdU
injection (Figure 3A), we found that a lower proportionferating NPCs (red) labeled by 30 min single-pulse BrdU injection in
ortex of embryonic forebrain.
ta are represented as means. n = 3 for each group. Error bars indicate
bar, 50 mm. See also Figure S1.
Authors
Figure 2. VPA-Treated Mice Perform
Poorly in Learning and Memory Tests
(A) Experimental timeline of prenatal VPA
treatment and postnatal behavior tests.
E, embryonic day; w, weeks old.
(B) VPA-treated mice have a lower correct-
arm alternation than MC-treated mice
(control).
(C–E) VPA-treated mice have a lower
freezing response than MC-treated mice
(control) in conditioning (C; day 1),
contextual (D; day 2), and cued fear asso-
ciative tests (E; day 3). See also Figures
S4A, S4C, and S4E for time course of
freezing response and Table S1 for a sum-
mary of behavior data.
MC, prenatal methylcellulose (vehicle); VPA, prenatal valproic acid. Data are represented as means. n = 12 for each group. Error
bars indicate the SD. *p < 0.05, **p < 0.01, two-tailed t test. See also Figure S4 and Table S1.of BrdU-retaining cells had differentiated into NEUN-pos-
itive neurons and S100b-positive astrocytes in VPA-treated
mice than in MC-treated mice (Figure 3D). The possibility
that more BrdU-retaining cells had died in VPA-treated
mice during the 4-week period can be ruled out, because
the survival rate of BrdU-retaining cells in these mice was
similar to that in MC-treated mice (Figure 3E). These re-
sults imply that BrdU-retaining cells in VPA-treated mice
either differentiated to another cell type(s) or differenti-
atedmore slowly than those inMC-treated mice. The latter
explanation is more plausible, because we found that a
higher proportion of BrdU-retaining cells in VPA-treated
mice still expressed SOX2 (an NPC marker) and KI-67
(a proliferationmarker) even 4 weeks after the last BrdU in-
jection (Figures S2C–S2E). We also found that 1 day after
the last BrdU injection, almost all BrdU-positive cells
were still KI-67-positive in VPA-treated mice, whereas
several BrdU-positive but KI-67-negative cells already ex-
isted in MC-treated mice (Figure S2F). We also examined
amygdala and cortex, other brain regions that were sug-
gested to play important roles in the regulation of memory
and fear associative responses (LeDoux, 2003; van Strien
et al., 2009). It has been shown previously that amygdala
volume associates with differences in fear associative
responses (Yang et al., 2008). However, we found that
VPA-treated mice have a similar amygdala size to that of
MC-treated mice, both at P7 and P84 (Figures S3A–S3D).
We also found no significant difference in the expression
level of cortical layer-specific genes such as Cux1, Satb2,
and Ctip2 (Molyneaux et al., 2007) in the cortex of P84
VPA-treated mice (Figures S3E–S3G). Taken together, these
results suggest that prenatal VPA treatment has the long-
term effect of impairing adult neurogenesis and contribute
to the poor performance of VPA-exposed mice in learning
and memory tests.Stem Cell RVoluntary Running Restores Learning and Memory
Deficiencies in VPA-Treated Mice, Probably through
Increased Neurogenesis that Yields Neurons with
Normal Morphology
Voluntary running can increase adult neurogenesis in the
hippocampal DG (van Praag et al., 1999a, 1999b). We
next provided the mice with a running wheel (RW) after
they had weaned and repeated the same BrdU-injection
experiment when they reached 12 weeks (P84; Figure 3A).
We observed an increased number of BrdU-retaining cells
in MC- and VPA-treated mice with the RW, both 1 day
and 4 weeks after the last BrdU injection (Figures 4A and
4B). We also found an increased proportion of BrdU-retain-
ing cells that had differentiated into NEUN-positive neu-
rons and a reduced proportion of BrdU-retaining cells
that still SOX2-positive in MC- and VPA-treated mice
with the RW, 4 weeks after the last BrdU injection (Figures
3A, 4C, and 4D). Voluntary running also enabled VPA-
treated mice to perform better in hippocampus-dependent
learning and memory test, the correct alternation in
Y-maze (F(1, 13) = 22.74, p < 0.001, one-way ANOVA),
and this performance was not significantly different in
comparison toMC-treatedmice (Figure 4E; Table S2).More-
over, we found that voluntary running also led VPA-treated
mice performing better in conditioning (F(1, 13) = 3.06,
p = 0.10, one-way ANOVA) and cued fear tests (F(1, 13) =
6.80, p < 0.05, one-way ANOVA), although not in contex-
tual fear test (F(1, 13) = 0.47, p = 0.50, one-way ANOVA).
As each mouse showed similar normal fear response, the
performance of VPA-treated mice after voluntary running
in conditioning and cued fear tests, but not in contextual
fear test, recovered to levels that were not significantly
different from that of MC-treated mice (Figures 4F–4H,
S4B, S4D, and S4F; Table S2). However, when we analyzed
all experimental groups by two-way ANOVA with botheports j Vol. 5 j 996–1009 j December 8, 2015 j ª2015 The Authors 999
Figure 3. Prenatal VPA Treatment Has
the Long-Term Effect on the Adult Neuro-
genesis
(A) Experimental timeline of prenatal VPA
treatment and adult neurogenesis analysis.
E, embryonic day; P, postnatal day; 1d,
1 day after the last intraperitoneal (i.p.)
BrdU injection; 4w, 4 weeks after the last
i.p. BrdU injection.
(B) Representative images of brain sections
including the hippocampal DG stained for
BrdU (red) and with Hoechst 33258
(blue),1 day after the last BrdU injection.
See also Figure S2A for KI-67 staining.
(C) Quantification of BrdU+ cells in the
granule cell layer (GCL), 1 day (1d; n = 8 for
each group) and 4 weeks (4w; n = 8 for each
group) after the last BrdU injection, shows
a reduction of BrdU+ cells in the hippo-
campus. See also Figure S2B for quantifi-
cation of KI-67+ cells in the GCL.
(D) NPC differentiation into NEUN+ neurons
and S100b+ astrocytes is impaired in VPA-
treated mice, as shown by a reduced proportion of marker-positive and BrdU+ cells among total BrdU+ cells at 4 weeks after the last BrdU
injection (n = 4 for each group).
(E) BrdU+ cell survival is similar in VPA- and MC-treated mice. Quantification of BrdU+ cell survival in each group as a percentage of BrdU+
cells at 4w relative to BrdU+ cells at 1d (n = 8 for each group).
MC, prenatal methylcellulose (vehicle); VPA, prenatal valproic acid. Data are represented as means. Error bars indicate the SD. *p < 0.05,
**p < 0.01, ***p < 0.001, n.s., not significantly different, two-tailed t test. Scale bar, 100 mm. See also Figures S2 and S3.prenatal treatment and postnatal activity as factors, the re-
sults did not show a significant effect of postnatal activity
on the performance of mice in hippocampus-dependent
learning and memory tests (Table S2). This is mainly
because voluntary running in MC-treated mice made
no significant contribution to the performance in hippo-
campus-dependent learning and memory tests (condi-
tioning: F(1, 13) = 0.13, p = 0.72; contextual: F(1, 13) =
0.26, p = 0.62; cued: F(1, 13) = 0.01, p = 0.93; Y-maze:
F(1, 13) = 1.17, p = 0.30; one-way ANOVA). In addition,
we found no significant interaction between prenatal
drug treatment and postnatal activity in relation to the
behavior of mice, except for the correct alternation in
Y-maze (F(1, 26) = 5.59, p < 0.05, two-way ANOVA;
Table S2). Therefore, it seems likely that only a certain
level of adult neurogenesis is required for mice to
perform normally in these hippocampus-dependent
learning and memory tests, so that MC-treated mice
with or without a RW showed no significant differences
in these tests even though MC-treated mice with a RW
displayed higher levels of neurogenesis than those
without one. However, because the level of adult
neurogenesis in the VPA-treated mice was below this
threshold, the mice performed poorly in these tests;
voluntary running improved their performance, probably1000 Stem Cell Reports j Vol. 5 j 996–1009 j December 8, 2015 j ª2015 Theby increasing adult neurogenesis in the hippocampus to
above the threshold level.
We next sought to determine whether adult neurogene-
sis in the DG of VPA-treated mice generated normal or
abnormal neurons. We found that DCX-positive immature
neurons (Figures 5A and S5A) and Golgi-stained mature
neurons (Figures 5B and S5B) in the DG of VPA-treated
mice displayed an abnormalmorphologywith shorter total
dendritic length (Figures 5D and 5E) and fewer dendrite
processes toward the molecular layer, as shown by a wider
maximum dendritic span compared to MC-treated mice
(Figure 5G). The dendritic complexity of Golgi-stained neu-
rons in VPA-treated mice, however, was similar to that of
MC-treated mice (Figures 5F and S5B). Surprisingly, this
abnormal morphology could also be overcome by volun-
tary running (Figures 5A, 5B, 5D, 5E, 5G, S5A, and S5B).
Taken together, these observations suggest that the restora-
tion of learning and memory deficiencies in VPA-treated
mice through running is involved in increased neurogene-
sis, which gives rise to neurons with normal morphology.
Several mechanisms have been proposed to be respon-
sible for the voluntary running-induced increase in adult
hippocampal neurogenesis. Voluntary running can induce
expression of neurotrophic factors such as brain-derived
neurotrophic factor (Bdnf) in the hippocampus (van Praag,Authors
Figure 4. Voluntary Running Restores Adult Neurogenesis and Cognitive Deficiencies of VPA-Treated Mice
(A) Representative images of brain sections including the hippocampal DG stained for BrdU (green) and with Hoechst 33258 (blue), 1 day
after the last BrdU injection. See Figure 2A for the experimental timeline.
(B) Quantification of BrdU+ in the granule cell layer (GCL), 1 day (1d; n = 8 for each group) and 4 weeks (4w; n = 8 for each group) after the
last BrdU injection, shows an increased number of BrdU+ cells in the hippocampus after voluntary running.
(C and D) Voluntary running recovers the proportion of BrdU+ cells that had differentiated into NEUN+ neurons (C) and the ones that still
expressed SOX2 (D) among total BrdU+ cells at 4 weeks after the last BrdU injection (n = 4 for each group).
(E) Reduction of correct-arm alternation in Y-maze tests of VPA-treated mice is recovered by voluntary running (n = 7 for MC and VPA + RW;
n = 8 for MC + RW and VPA).
(F–H) Voluntary running recovers the freezing response in conditioning (F; day 1) and in cued fear associative tests (H; day 3), but not in
contextual fear associative tests (G; day 2; n = 7 for MC and VPA + RW; n = 8 for MC + RW and VPA). See also Figures S4B, S4D, and S4F for the
time course of the freezing response and Table S2 for a summary of behavior data.
MC, prenatal methylcellulose (vehicle); MC + RW, prenatal methylcellulose and postnatal running; VPA, prenatal valproic acid; VPA + RW,
prenatal valproic acid and postnatal running. Data are represented as means. Error bars indicate the SD. *p < 0.05, **p < 0.01,
***p < 0.001, n.s., not significantly different, two-tailed t test. Scale bar, 100 mm. See also Figure S4 and Table S2.2009; Farmer et al., 2004), and Bdnf has been suggested to
have an important role in adult neurogenesis, neuronal
maturation, and dendrite arborization (Tolwani et al.,Stem Cell Re2002; Bekinschtein et al., 2011; Stranahan, 2011). Indeed,
we found an increased level of Bdnf expression after
running in both MC- and VPA-treated mice hippocampusports j Vol. 5 j 996–1009 j December 8, 2015 j ª2015 The Authors 1001
Figure 5. Voluntary Running Restores Neuronal Morphology in VPA-Treated Mice
(A) Impaired morphology of DCX+ young neurons in the DG of VPA-treated mice is recovered by voluntary running (n = 4 for each group).
Scale bar, 100 mm.
(B) Impaired morphology of Golgi-Cox stained neurons in the DG of VPA-treated mice is recovered by voluntary running (n = 3 for each
group). Note that voluntary running recovered non-molecular layer-oriented dendrites in VPA-treated mice to molecular layer-oriented
ones. Scale bar, 100 mm.
(C) Impaired morphology of Golgi-Cox stained neurons in the CA1 of VPA-treated mice is not recovered by voluntary running (n = 3 for each
group). Note that the less-ramified and straighter apical dendrites in VPA-treated mice could not be recovered by voluntary running.
Scale bar, 50 mm.
(D–F) Voluntary running recovers total dendritic length of DCX+ young neurons (D) and Golgi-Cox stained neurons (E) and increases
dendritic complexity of Golgi-Cox stained neurons (F) in the DG of VPA-treated mice. See also Figures S5A and S5B for Sholl analysis.
(G–I) Abnormal dendritic span of DG neurons (G), but not of apical dendritic span of CA1 neurons (I), is recovered by voluntary running in
VPA-treated mice, while basal dendrites of CA1 neurons show similar dendritic span across groups (H).
MC, prenatal methylcellulose (vehicle); MC + RW, prenatal methylcellulose and postnatal running; VPA, prenatal valproic acid; VPA + RW,
prenatal valproic acid and postnatal running. Data are represented as means. Error bars indicate the SD. *p < 0.05, ***p < 0.001, n.s., not
significantly different, two-tailed t test. See also Figure S5.
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Figure 6. Voluntary Running Increases the Bdnf Expression Level and Reduces Microglia and Activated Microglia in the
Hippocampus
(A) The expression level of brain-derived neurotrophic factor (Bdnf) was increased by voluntary running in both MC- and VPA-treated mice.
(B–D) Voluntary running reduced the number of IBA1+ microglia (red; B and C) and CD68+-activated microglia (green; B and D) in both MC-
and VPA-treated mice.
MC, prenatal methylcellulose (vehicle); MC + RW, prenatal methylcellulose and postnatal running; VPA, prenatal valproic acid; VPA + RW,
prenatal valproic acid and postnatal running; Gapdh, glyceraldehyde 3-phosphate dehydrogenase. Data are represented as means. n = 3 for
each group. Error bars indicate the SD. *p < 0.05, **p < 0.01, two-tailed t test. Scale bar, 100 mm.(Figure 6A). Voluntary running has also been shown to
reduce the number of microglia and its activation (Gebara
et al., 2013; Kohman et al., 2013), and previous reports
showed that microglia can suppress the adult hippocampal
neurogenesis (Sierra et al., 2010; Vukovic et al., 2012; Mat-
suda et al., 2015). Interestingly, we found that the number
of IBA1-positivemicroglia andCD68-positive-activatedmi-Stem Cell Recroglia was also decreased by voluntary running in both
MC- and VPA-treated mice (Figures 6B–6D). Therefore, it
is plausible that voluntary running helped VPA-treated
mice through the increased adult hippocampal neurogene-
sis that was caused by the increase level of Bdnf expression
and the reduction ofmicroglia and its activated form in the
hippocampus.ports j Vol. 5 j 996–1009 j December 8, 2015 j ª2015 The Authors 1003
Figure 7. Voluntary Running Restores Neuronal Activity in VPA-Treated Mice
(A) Representative pseudocolor activity map images of brain slices including the hippocampus show that voluntary running can only
recover the impairment of GABAA receptor-mediated inhibition in the mossy fiber pathway (msy) of VPA-treated mice, after treatment with
the GABAA receptor channel antagonist picrotoxin (PITX) (n = 6 for MC, n = 9 for MC + RW, n = 7 for VPA, n = 8 for VPA + RW). Electrical
stimulation was applied to Schaffer collateral afferents at the CA3/CA1 border of CA1 (sch); to the granule cell layer to stimulate the mossy
fiber pathway (msy); and to the molecular layer of the upper blade in the DG (pp).
(B) Quantification of the neural response in artificial cerebrospinal fluid (ACSF), with (black bars) or without PITX (white bars; n = 6 for MC,
n = 9 for MC + RW, n = 7 for VPA, n = 8 for VPA + RW). Note that although the augmentation of the neural response caused by GABAA
receptor-mediated inhibition with PITX application seen in sch and msy was abolished in VPA-treated mice, voluntary running could
restore the augmentation only in the msy.
MC, prenatal methylcellulose (vehicle); MC + RW, prenatal methylcellulose and postnatal running; VPA, prenatal valproic acid; VPA + RW,
prenatal valproic acid and postnatal running. Data are represented as means. Error bars indicate the SD. *p < 0.05, ***p < 0.001, two-tailed
t test.Voluntary Running Cannot Mitigate Abnormal
Neuronal Morphology or Function of the
Hippocampal CA1 Region in VPA-Treated Mice
The freezing response in the contextual fear test after
voluntary running by VPA-treated mice did not recover to
the level displayed by MC-treated mice (Figures 4G and
S4D; Table S2). It has been proposed that recall of contex-
tual memories relies more on CA1 than other regions in
the hippocampus (Hall et al., 2001). Indeed, we found
that apical dendrite morphology was abnormal in CA1
neurons of VPA-treated mice, and this defect was not re-
paired by voluntary running (Figures 5C, 5H, and 5I).
Moreover, when we examined the region-specific restora-
tion by voluntary running of neuronal activity in the hip-
pocampus, the basal neuronal responses upon electrical
stimulation were not affected by VPA nor voluntary
running in the three major synaptic connections in the
hippocampus (CA3-CA1, Schaffer collateral afferent [sch];
DG-CA3, mossy fiber [msy]; EC-DG, perforant pathway
[pp]) possibly due to some homeostatic balancing mecha-
nism (Turrigiano and Nelson, 2004; Turrigiano, 2011).
However, when the excitatory activity was measured,
with the increase in activity caused by an inhibitor for1004 Stem Cell Reports j Vol. 5 j 996–1009 j December 8, 2015 j ª2015 TheGABAA receptor picrotoxin (PITX) application, the effect
of VPA became apparent. That is, the PITX induced an in-
crease in sch and msy in MC-treated mice, which was not
seen in VPA-treated mice, suggesting the impairment of
inhibitory action in VPA-mice. The voluntary running
could restore the characteristics only in msy (Figure 7).
These results may explain why the recovery of neurogene-
sis and neuronal morphology of the DG in VPA-treated
mice could not ameliorate their poor performance in the
contextual associative test. Previous studies have indicated
that ablation of adult neurogenesis in the DG leads to
defective performance in a contextual associative test
(Saxe et al., 2006; Wojtowicz et al., 2008) (but see Shors
et al., 2002), but enhanced neurogenesis or running was
weakly related to the performance in the test (Wojtowicz
et al., 2008).DISCUSSION
The precise pathology underlying postnatal impairment of
cognitive function in children of epileptic expectant
mothers treated with VPA, commonly used AED, isAuthors
unknown. Based on our findings in mice, we propose that
the impairment is attributable to the untimely enhance-
ment of embryonic neurogenesis, which leads to depletion
of the NPC pool and consequently to a decreased level of
postnatal neurogenesis in the hippocampus. Children of
epileptic expectant mothers treated with VPA may also
have hippocampal neurons with abnormal morphology
and activity, as were observed in this study. Although pre-
natal exposure to AEDs such as VPA may have detrimental
effects that persist until adulthood, we suggest that these
effects could be mitigated by a simple physical activity
such as running. Our results thus offer a straightforward
strategy to help children born to epileptic mothers.
The cognitive deficits associated with prenatal VPA expo-
suremight not due solely to the reduced neurogenesis with
the abnormal neuronal morphology in the hippocampus,
and there is a possibility that the low freezing responses
in fear associative tests were contributed by the deficiency
in amygdala, nociception, and/or motoric functions.
Nevertheless, our data suggested that the reduced neuro-
genesis associated with the abnormal neuronal mor-
phology in the hippocampus were very likely to be
correlated with the observed cognitive deficits for several
reasons. First, voluntary running is well known for its effect
on enhancing both adult neurogenesis in the DG of the
hippocampus and hippocampus-dependent learning and
memory (Zhao et al., 2008), and this voluntary running
could recover the cognitive deficit, if not all, in VPA-treated
mice with reduced neurogenesis in the DG. Second, to the
best of our knowledge, there are no reports to date that
show a direct contribution of voluntary running to the
enhancement of amygdala function that subsequently
leads to an improvement in the cued fear response. Third,
based on experiments that we have conducted, we could
not find any significant differences in amygdala size and
in the expression levels of cortical layer-specific genes of
MC- and VPA-treated mice, with or without voluntary
running. Fourth, total traveled distance in the open field,
elevated plus and the Y-maze tests, and the number of
light/dark transitions were not significantly different be-
tween MC- and VPA-treated mice, although in our earlier
experiment some of these parameters showed modest dif-
ferences. Moreover, in fear associative test, VPA-treated
mice move similarly to MC-treated mice before the start
of the tone (pre-tone), which indicate that motor defi-
ciency is unlikely to be the main cause of low freezing re-
sponses in VPA-treated mice. Fifth, MC- and VPA-treated
mice have similar basal nociceptive response and startle
response to electric footshock during the conditioning for
fear-associative test, thus it seems unlikely that VPA-treated
mice have abnormal nociception and cannot sense the foot
shock. Taking these facts into consideration, we therefore
suggested that the reduced neurogenesis associated withStem Cell Rethe abnormal neuronal morphology in the hippocampus
were very likely to be a critical cause of the observed
cognitive deficits. However, we still cannot completely
exclude the possibility that changes in other brain areas
may also contribute to the deficits, warranting further
future investigation.
We and others have shown previously that VPA treat-
ment induces neuronal differentiation but suppresses glial
differentiation of cultured multipotent NPCs (Hsieh et al.,
2004; Balasubramaniyan et al., 2006; Murabe et al., 2007;
Abematsu et al., 2010; Juliandi et al., 2012). We have now
demonstrated that VPA also increases histone acetylation
in the embryonic forebrain and induces neuronal differen-
tiation of embryonic NPCs. Previous study have shown
that VPA promotes neuronal differentiation by increasing
histone H4 acetylation at proneural gene promoters (Yu
et al., 2009). However, several studies have suggested that
the activation of GSK-3b/b-catenin and/or ERK pathway
is the main cause for the increase neurogenesis of NPCs
by VPA (Yuan et al., 2001; Jung et al., 2008; Hao et al.,
2004; Go et al., 2012). It has been suggested that VPAmight
have various cellular effects that will depend on the
context of VPA usage and/or cell type and experimental
design used in the study, which warrant further research
to reveal the connection between these effects (Kostrou-
chova´ et al., 2007; Rosenberg, 2007).
We suggest that gene expression change caused by VPA is
attributable mainly to its HDAC-inhibiting activity. To
date, more than a dozen HDACs have been characterized
and they are classified into at least three major groups. In
particular, HDAC1 and HDAC2, belonging to the class I
group, have been reported to regulate NPC differentiation
(Sun et al., 2011). NPCs express high levels of HDAC1
and some of them also express low levels of HDAC2
(MacDonald and Roskams, 2008). Interestingly, as NPCs
are committed to the neuronal lineage, expression of
HDAC2 is upregulated while that of HDAC1 is downregu-
lated and becomes undetectable in most post-mitotic neu-
rons (MacDonald et al., 2005; MacDonald and Roskams,
2008); on the other hand, HDAC1 expression is sustained
in the majority of cells in glial lineages (astrocytes and oli-
godendrocytes), in which HDAC2 is not detected (Shen
et al., 2005; MacDonald and Roskams, 2008). Moreover,
HDAC2, but not HDAC1, was found to inhibit astrocytic
differentiation (Humphrey et al., 2008). Therefore,
although VPA is capable of inhibiting both HDAC1 and
HDAC2 (Kazantsev and Thompson, 2008), it is tempting
to speculate that the main target of VPA in HDAC
inhibition-mediated neuronal differentiation of NPCs is
HDAC1. It will be of interest to explore this possibility in
a future study.
Neurogenesis in the adult mammalian brain occurs
throughout life and has been clearly demonstrated at twoports j Vol. 5 j 996–1009 j December 8, 2015 j ª2015 The Authors 1005
locations under physiological conditions: the SVZ of the
lateral ventricle and the subgranular zone (SGZ) of the
DG in the hippocampus (Alvarez-Buylla and Lim, 2004).
Several studies have shown that hippocampal neurogene-
sis is regulated by both physiological and pathological ac-
tivities at different stages, including (1) proliferation of
NPCs, (2) fate determination and differentiation of NPCs,
and (3) survival, maturation, and integration of newborn
neurons (Zhao et al., 2008). Furthermore, each of these
stages is subject to regulation by numerous intrinsic and
extrinsic factors (Suh et al., 2009). Genetic and environ-
mental factors that affect adult hippocampal neurogenesis
also cause alteration in cognitive performance, suggesting
roles for adult hippocampal neurogenesis in learning and
memory (Zhao et al., 2008). Our results showed that VPA-
treated mice have a decreased level of postnatal neurogen-
esis in the hippocampus, which correlates with their poor
performance in learning and memory tests. We have
shown here and elsewhere (Hsieh et al., 2004; Jessberger
et al., 2007) that VPA can reduce the proliferation of
NPCs, and this reduction, together with the enhancement
of neurogenesis, probably led to the depletion of the NPC
pool in VPA-treated mice. It is possible that this depletion
caused a slower differentiation of the residual NPCs in
order to maintain required number of NPC pool during
life. This possibility is an interesting avenue to be explored
in the future.
In accordance with previous studies (van Praag et al.,
1999a, 1999b), we found that voluntary running augments
hippocampal neurogenesis of both MC- and VPA-treated
mice, and it restores learning and memory deficiencies in
VPA-treated mice. A previous report has shown the same
restoration of decreased hippocampal neurogenesis and
learning deficits in aged rodents by voluntary running
(van Praag et al., 2005), although the precise molecular
mechanisms responsible for voluntary running-induced
neurogenesis remain undetermined (Deng et al., 2010).
Here, we propose that at least the increase expression level
of Bdnf, and the reduction of activated microglia may
contribute to the restoration of impaired hippocampal
neurogenesis and neuronal morphology in the DG of
VPA-treated mice after voluntary running. However, future
exploration is necessary to reveal the direct connection
between the increase expression level of Bdnf and the
reduction of microglia and its activated form in the hippo-
campus after voluntary running.EXPERIMENTAL PROCEDURES
Animal Treatment
All experiments were carried out according to institutional animal
experimentation guidelines, which complywith theNIHGuide for
Care andUse of Laboratory Animals. All efforts weremade tomini-1006 Stem Cell Reports j Vol. 5 j 996–1009 j December 8, 2015 j ª2015 Themize the number of animals used and their suffering. Pregnant
C57BL/6 mice were individually housed in plastic breeding cages
with free access to water and pellet diet in a 12-hr light-dark cycle.
For a detailed description of groups and treatments, see the Supple-
mental Experimental Procedures.
Immunohistochemistry, Nissl, and Golgi Staining
Mice were anesthetized and perfused with PBS followed by
4% PFA in PBS. The brain was dissected, postfixed, and pro-
cessed for immunohistochemistry. For Nissl staining, brain sec-
tions were defatted with xylene, hydrated through a graded
ethanol series (100%, 95%, and 70%), and washed with
water before stained with 0.2% thionin solution (pH 4.0).
Sections were then dehydrated in water and a graded ethanol
series (70%, 95%, and 100%), clear in xylene, and mounted
with Entellan (Merck). For Golgi staining, the brain was
removed from the skull without any perfusion and then
sectioned (100 mm) on a cryostat. For a more detailed description
and list of antibodies, see the Supplemental Experimental
Procedures.
Measurement and Morphometrics
For a detailed description of cell count, volume measurement and
cell/tissue morphometrics, see the Supplemental Experimental
Procedures.
Gene Expression Analysis
For a detailed description of GeneChip and real-time qPCR proce-
dures, see the Supplemental Experimental Procedures.
Behavioral Tests
Behavioral experiments were performed sequentially using male
mice. For a more detailed description, see the Supplemental Exper-
imental Procedures.
Voltage-Sensitive Dye Imaging
Experiment was done using hippocampal slices. For a more
detailed description, see the Supplemental Experimental
Procedures.
Statistics
Statistical analyses were performed by Student’s two-tailed t test
(unpaired) and one-way or two-way ANOVA using R software
(http://www.r-project.org) (n indicates individual mice).
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